AbbVie Inc.
ABBV
$236.19
$2.331.00%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.34% | 2.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.34% | 2.29% | |||
| Cost of Revenue | 2.13% | 2.55% | |||
| Gross Profit | 6.60% | 2.18% | |||
| SG&A Expenses | 11.41% | 7.70% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.61% | 5.60% | |||
| Operating Income | 1.21% | -3.23% | |||
| Income Before Tax | 273.67% | -54.05% | |||
| Income Tax Expenses | 62.17% | -14.19% | |||
| Earnings from Continuing Operations | 865.43% | -80.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 150.00% | 33.33% | |||
| Net Income | 876.34% | -80.17% | |||
| EBIT | 1.21% | -3.23% | |||
| EBITDA | -0.10% | -2.22% | |||
| EPS Basic | 923.12% | -81.04% | |||
| Normalized Basic EPS | 0.01% | -1.28% | |||
| EPS Diluted | 923.12% | -80.87% | |||
| Normalized Diluted EPS | 0.18% | -1.28% | |||
| Average Basic Shares Outstanding | 0.28% | 0.06% | |||
| Average Diluted Shares Outstanding | 0.11% | 0.06% | |||
| Dividend Per Share | 5.49% | 0.00% | |||
| Payout Ratio | -0.90% | 4.04% | |||